Correlation Between Neurocrine Biosciences and 251566AA3
Specify exactly 2 symbols:
By analyzing existing cross correlation between Neurocrine Biosciences and DT 3625 21 JAN 50, you can compare the effects of market volatilities on Neurocrine Biosciences and 251566AA3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of 251566AA3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and 251566AA3.
Diversification Opportunities for Neurocrine Biosciences and 251566AA3
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurocrine and 251566AA3 is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and DT 3625 21 JAN 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DT 3625 21 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with 251566AA3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DT 3625 21 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and 251566AA3 go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and 251566AA3
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 2.51 times more return on investment than 251566AA3. However, Neurocrine Biosciences is 2.51 times more volatile than DT 3625 21 JAN 50. It trades about -0.02 of its potential returns per unit of risk. DT 3625 21 JAN 50 is currently generating about -0.09 per unit of risk. If you would invest 12,147 in Neurocrine Biosciences on December 10, 2024 and sell it today you would lose (1,060) from holding Neurocrine Biosciences or give up 8.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 59.35% |
| Values | Daily Returns |
Neurocrine Biosciences vs. DT 3625 21 JAN 50
Performance |
| Timeline |
| Neurocrine Biosciences |
| DT 3625 21 |
Neurocrine Biosciences and 251566AA3 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and 251566AA3
The main advantage of trading using opposite Neurocrine Biosciences and 251566AA3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, 251566AA3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 251566AA3 will offset losses from the drop in 251566AA3's long position.| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
| 251566AA3 vs. Summit Hotel Properties | 251566AA3 vs. RCI Hospitality Holdings | 251566AA3 vs. Artisan Partners Asset | 251566AA3 vs. Playa Hotels Resorts |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |